[Inhibitory effect of green tea infusion of hepatotoxicity]. 1998

R Hasegawa, and K Takekida, and K Sai, and T Umemura, and A Tanimura, and T Inoue, and Y Kurokawa
hasegawa@nihs.go.jp

We first showed a drinking of green tea infusion can inhibit chemically induced possible hepatic tissue damages in animal experiments, although it has been shown that oral administration of green tea extract can inhibit some organ toxicities. In this review, our data are summarized and a possibility of the effectiveness in humans is discussed. Male rats or mice in the series of experiments were given 2% green tea infusion as a drinking water 1 or 2 weeks before the chemical treatment and until the termination. In the study of rats, green tea effectively inhibited the hepatotoxicity induced by a single intraperitoneal injection or by repeated gavage administration of 2-nitropropane, and a single intraperitoneal injection of galactosamine. However, any possible effects were not observed when green tea was given, on the hepatotoxicity by a single or repeated gavage administration of carbon tetrachloride. In the study of mice, green tea inhibited the hepatotoxicity induced by administration of pentachlorophenol in diet. In conclusion, 2% green tea infusion can prevent the hepatotoxicity by at least some chemicals in experimental animals. It is inferred that the amount of green tea taken by animals in this experiment might be equivalent to the daily intake in Japanese general population, by calculation based on the content of epigallocatechin gallate, a major component of green tea, and the species differences between experimental animals and humans, suggesting the preventive effectiveness in humans.

UI MeSH Term Description Entries
D008297 Male Males
D009595 Nitroparaffins Alkanes having one or more nitro (NO2) groups attached to carbon atoms.
D010416 Pentachlorophenol An insecticide and herbicide that has also been used as a wood preservative. Pentachlorphenol is a widespread environmental pollutant. Both chronic and acute pentachlorophenol poisoning are medical concerns. The range of its biological actions is still being actively explored, but it is clearly a potent enzyme inhibitor and has been used as such as an experimental tool. Sodium Pentachlorophenate,Pentachlorophenate, Sodium
D011407 Propane A three carbon alkane with the formula H3CCH2CH3.
D002251 Carbon Tetrachloride A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed) Tetrachloromethane,Tetrachloride, Carbon
D002392 Catechin An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms. Catechinic Acid,Catechuic Acid,(+)-Catechin,(+)-Cyanidanol,(+)-Cyanidanol-3,(-)-Epicatechin,(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol,2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-,3,3',4',5,7-Flavanpentol,Catergen,Cianidanol,Cyanidanol-3,Epicatechin,KB-53,Z 7300,Zyma,Cyanidanol 3,KB 53,KB53
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D005688 Galactosamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R Hasegawa, and K Takekida, and K Sai, and T Umemura, and A Tanimura, and T Inoue, and Y Kurokawa
August 2015, Archives of toxicology,
R Hasegawa, and K Takekida, and K Sai, and T Umemura, and A Tanimura, and T Inoue, and Y Kurokawa
March 2013, Journal of clinical and experimental hepatology,
R Hasegawa, and K Takekida, and K Sai, and T Umemura, and A Tanimura, and T Inoue, and Y Kurokawa
August 2007, Free radical biology & medicine,
R Hasegawa, and K Takekida, and K Sai, and T Umemura, and A Tanimura, and T Inoue, and Y Kurokawa
April 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
R Hasegawa, and K Takekida, and K Sai, and T Umemura, and A Tanimura, and T Inoue, and Y Kurokawa
October 2014, Journal of toxicologic pathology,
R Hasegawa, and K Takekida, and K Sai, and T Umemura, and A Tanimura, and T Inoue, and Y Kurokawa
July 2023, Foods (Basel, Switzerland),
R Hasegawa, and K Takekida, and K Sai, and T Umemura, and A Tanimura, and T Inoue, and Y Kurokawa
May 1992, Preventive medicine,
R Hasegawa, and K Takekida, and K Sai, and T Umemura, and A Tanimura, and T Inoue, and Y Kurokawa
December 1995, Shanghai kou qiang yi xue = Shanghai journal of stomatology,
R Hasegawa, and K Takekida, and K Sai, and T Umemura, and A Tanimura, and T Inoue, and Y Kurokawa
January 2000, Atherosclerosis,
R Hasegawa, and K Takekida, and K Sai, and T Umemura, and A Tanimura, and T Inoue, and Y Kurokawa
June 2018, Archives of virology,
Copied contents to your clipboard!